Pay in 4 interest-free payments of $5.82 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Safety Profile: What 2026 Data Tells Us Discontinuation appears lowest in the diabetes-specific TRANSCEND-T2D-1 population the reason isn't fully established but may relate to population or trial-duration differences
The key word is "managed." AOD-9604 is not a shortcut, and it is not for everyone
GLP-1s are not a magic bullet, but they are one of the most effective tools weve ever had for improving metabolic health
However, it is noteworthy that a considerable number of our clients have experienced weight loss of up to 22% of their body weight within one year.* Individuals who experience gradual and consistent weight loss, typically at a rate of 1.5 to 2.5 pounds per week, are more likely to maintain their weight compared to those who lose weight rapidly
It is not a standalone cure for obesity but a tool to support a holistic weight management plan
Not a cure for MCAS, nor for anything else theyve been shown to help
